Genomic Life

Genomic Life is changing the healthcare paradigm by accelerating access to affordable and engaging genomics-based, proactive health solutions.

Contact Info

3344 N Torrey Pines Ct, Suite 100
La Jolla, CA 92037
info@genomiclife.com
844-694-3666

Learn More

Follow Us

We are entering the genomics era

Until recently, genomics has been fragmented, niche, and expensive. All of that has changed, and genomics now has something to offer you, your family, and your healthcare providers at every stage of your life.

unimpacted person
unimpacted person
unimpacted person
unimpacted person
impacted person
unimpacted person
unimpacted person
impacted person
impacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
impacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
impacted person
unimpacted person
unimpacted person
unimpacted person
impacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
impacted person
impacted person
unimpacted person
unimpacted person
unimpacted person
impacted person
impacted person
unimpacted person
unimpacted person
impacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
impacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
impacted person
impacted person
unimpacted person
impacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
impacted person
16%
of the population has an inherited mutation for a medically-actionable condition¹

In a study of over 10,000 adults, ~16% of the study participants were found to have a high-impact or moderate-impact inherited mutation. Of those that tested positive, the majority had pre-disposing variants related to hereditary cancer syndromes or variants associated with cardiovascular disorders. We believe that proactive genetic health screening should be accessible and affordable for everyone that wants it.

unimpacted person
impacted person
impacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
impacted person
unimpacted person
unimpacted person
unimpacted person
impacted person
unimpacted person
unimpacted person
unimpacted person
impacted person
unimpacted person
unimpacted person
unimpacted person
impacted person
impacted person
unimpacted person
unimpacted person
impacted person
unimpacted person
impacted person
impacted person
unimpacted person
impacted person
unimpacted person
unimpacted person
impacted person
unimpacted person
unimpacted person
unimpacted person
impacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
impacted person
impacted person
impacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
impacted person
unimpacted person
impacted person
impacted person
impacted person
impacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
impacted person
impacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
impacted person
impacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
impacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
impacted person
unimpacted person
impacted person
unimpacted person
unimpacted person
impacted person
unimpacted person
impacted person
unimpacted person
unimpacted person
impacted person
unimpacted person
unimpacted person
impacted person
impacted person
unimpacted person
unimpacted person
impacted person
34%
of tumors harbor a mutation classified as a predictive biomarker of response to an FDA-approved drug³

In a cohort of 52,069 solid tumor samples 92% harbored at least one oncogenic mutation and 34% harbored at least one mutation classified as a predictive biomarker of response to an FDA-approved drug. We believe that comprehensive tumor profiling should be a part of routine care for cancer patients.

impacted person
impacted person
impacted person
unimpacted person
unimpacted person
impacted person
impacted person
unimpacted person
unimpacted person
unimpacted person
impacted person
unimpacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
unimpacted person
unimpacted person
unimpacted person
unimpacted person
impacted person
impacted person
impacted person
impacted person
unimpacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
unimpacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
unimpacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
unimpacted person
impacted person
impacted person
unimpacted person
unimpacted person
impacted person
impacted person
impacted person
unimpacted person
impacted person
impacted person
unimpacted person
impacted person
impacted person
impacted person
impacted person
unimpacted person
unimpacted person
unimpacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
unimpacted person
impacted person
78%
of the population carries at least one recessive condition that could impact their children or family²

Of patients tested for 301 genes on an expanded carrier screening panel, 78% of patients were found to be carriers of a mutation for a recessive condition. We believe that families should have access to the appropriate genetic counseling and testing to understand their genetic risks and inform family planning.

impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
unimpacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
unimpacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
unimpacted person
impacted person
impacted person
unimpacted person
unimpacted person
impacted person
impacted person
impacted person
unimpacted person
impacted person
impacted person
impacted person
impacted person
unimpacted person
impacted person
impacted person
impacted person
unimpacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
impacted person
unimpacted person
impacted person
impacted person
91%
of the population has an actionable variant that affects the way that they respond to different medications⁴

In a study of over 10,000 patients that underwent preemptive, panel-based pharmacogenomic testing, 91% of the patients were identified to have one or more actionable variant. We believe that pharmacogenomics is heavily under-utilized and should be available to everyone to tailor their treatment to their unique genetic makeup.